SCHEDULE: Deep Track Capital Discloses 5.17% Stake in Shattuck Labs

Deep Track Capital, LP, along with its affiliates, has reported beneficial ownership of 5,000,033 shares, representing 5.17% of the outstanding common stock of Shattuck Labs, Inc.

Summary

• Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin have jointly filed a Schedule 13G, indicating their beneficial ownership of Shattuck Labs, Inc. common stock.
• The total number of shares beneficially owned is 5,000,033, which constitutes 5.17% of the class of securities.
• This ownership level is calculated based on 95,508,165 shares outstanding as of June 11, 2026, and includes 1,293,299 Pre-Funded Warrants that are exercisable into common shares.
• The exercise of these warrants is subject to a 9.99% Maximum Percentage limitation, preventing the holder from beneficially owning more than 9.99% of the outstanding common stock after exercise.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting an ownership stake and warrant exercise limitations, without providing operational or financial performance updates from the issuer.

Positives

• Deep Track Capital has acquired a significant stake, indicating confidence in Shattuck Labs' potential.
• The acquisition of Pre-Funded Warrants suggests a strategic investment with potential for future upside.

Negatives

• The 9.99% Maximum Percentage exercise limitation on Pre-Funded Warrants restricts the immediate conversion of all warrants into common stock.

Risks

• The 9.99% Maximum Percentage limitation could prevent the full exercise of warrants if the ownership threshold is reached.
• Potential for future sales of shares by Deep Track Capital could impact Shattuck Labs' stock price.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance from Shattuck Labs, Inc. The information pertains to the ownership stake of Deep Track Capital.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically indicate passive investment stakes by institutional investors. The acquisition of over 5% of a biotechnology company like Shattuck Labs by a specialized fund like Deep Track Capital suggests a belief in the company's technology or market position, though the 9.99% exercise cap on warrants implies a cautious approach to control.

Stakeholder Impact

• Shareholders: The filing indicates a significant institutional investor's interest, which could be perceived positively, but the exercise limitations on warrants may temper immediate impact.
• Management: The increased institutional ownership may lead to closer scrutiny or engagement from Deep Track Capital.
• Creditors: No direct impact is indicated by this filing.

Next Steps

• Deep Track Capital may continue to monitor its investment in Shattuck Labs, Inc.
• The reporting persons will file amendments to this Schedule 13G if any material changes in beneficial ownership occur.

Key Dates

Keywords

Schedule 13G, Shattuck Labs, Deep Track Capital, Beneficial Ownership, Common Stock, Pre-Funded Warrants, SEC Filing, Investment